Colleen Elso

Title: Colleen Elso - Innovator in Nucleic Acid Diagnostics

Colleen Elso is a prominent inventor based in Northcote, Australia. She has made significant contributions to the field of nucleic acid diagnostics, particularly through her innovative patent.

Latest Patents

Colleen Elso holds a patent for a method titled "Nucleic acid diagnostics based on mass spectrometry or mass separation and base specific cleavage." This method involves detecting mutations or differences in nucleotides between a test nucleic acid molecule and a reference nucleic acid molecule. The process includes subjecting the test nucleic acid to base specific cleavage to generate oligonucleotide fragments. These fragments are then separated based on mass using MALDI-ATOF MS or equivalent procedures, producing a fingerprint of the oligonucleotide fragments. The presence of altered peaks in the resulting data indicates differences in nucleotides, showcasing the effectiveness of her method in genetic diagnostics.

Career Highlights

Colleen Elso is affiliated with the Walter and Eliza Hall Institute of Medical Research, where she continues to advance her research in medical diagnostics. Her work has been instrumental in enhancing the accuracy and efficiency of genetic testing, contributing to the broader field of medical research.

Collaborations

Colleen has collaborated with notable colleagues, including Simon Foote and Richard John Simpson. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas in the realm of medical research.

Conclusion

Colleen Elso's contributions to nucleic acid diagnostics exemplify her dedication to advancing medical research. Her innovative patent and collaborative efforts highlight her role as a key figure in the field.